Your fact-checks will appear here
Hospital in Los Angeles, California, United States
Clinical testing of ivermectin in oncology remains limited but active: registered phase I/II trials administer ivermectin orally on multi-day schedules within 21‑day cycles alongside intravenous immun...
No credible, mainstream reporting in the supplied sources documents any formal 2025 health disclosure or an announced retirement by Barbra Streisand; fan sites and tabloids have circulated speculation...
Barbra Streisand has been a prominent advocate for women’s cardiovascular health for years and her name is attached to clinical and advocacy efforts, but the reporting provided contains no credible, c...
Two clinical studies are publicly associated with testing , but only one—the phase I/II trial NCT05318469—has detailed, actively reported design elements: it combines oral ivermectin with an anti‑PD‑1...
No major news outlets in the provided reporting show Barbra Streisand issuing a personal public statement about her own health in 2025; available sources instead document her long-standing public advo...
Two registered early‑phase clinical trials combine ivermectin with immune checkpoint inhibitors for cancer: a phase I/II investigator‑initiated trial testing oral ivermectin with balstilimab (and an e...
No major mainstream outlets or Streisand’s representatives are cited in the provided reporting as confirming a new or serious medical condition for Barbra Streisand in 2025; one fact-check/summary sit...
No credible reporting in the provided sources asserts that Barbra Streisand is currently seriously ill; recent coverage emphasizes her ongoing public advocacy for women’s heart health and institutions...
Ivermectin in preclinical triple-negative breast cancer (TNBC) models acts through multiple, interconnected mechanisms that reshape the tumor immune microenvironment: it promotes immunogenic cancer ce...
No record in the supplied reporting shows Barbra Streisand posting a health-status update in 2025 on an official website or on her verified social-media accounts; available sources instead document ro...
The only published outcome from the ivermectin + immunotherapy TNBC effort tied to ClinicalTrials.gov identifier NCT05318469 through the end of 2025 is an ASCO 2025 meeting abstract reporting safety a...
Skin tags (acrochordons) are common, benign, flesh-coloured or darker little growths that most adults will develop at some point — roughly “about half” to “up to two‑thirds” of adults, depending on th...
No source in the provided search results reports that Barbra Streisand’s publicists or representatives issued a health statement about her in 2025; available sources discuss her long‑standing advocacy...
AI models exhibit measurable, systematic biases across tasks from hiring and healthcare to essay evaluation; studies and reviews show these biases arise mainly from training data, model design, and re...
Seek medical help for low body temperature (hypothermia) after flu or COVID if you have ongoing confusion, difficulty breathing, chest pain, fainting, or your temperature is persistently very low — es...
As of 2025, stem‑cell approaches — including mesenchymal stem cells, induced pluripotent stem cell (iPSC) derivatives, blood‑stem/progenitor and autologous adipose‑derived cells — are actively being r...
A single actively registered clinical trial testing has been identified: a Phase I/II study (NCT05318469) combining oral ivermectin with anti‑PD‑1 immune checkpoint therapy for (mTNBC), and its primar...
There are no records in the reporting reviewed that show Elon Musk or the Musk Foundation making philanthropic grants explicitly to urology departments or bladder-disease research centers; the Musk Fo...
There is no record in the supplied reporting of a recent first‑person public statement or social‑media post by Barbra Streisand specifically addressing her personal health; the most concrete material ...
Public reporting contains almost no verifiable, recent medical information about Barbra Streisand’s personal health; what is consistently documented is her long-standing activism on women’s cardiovasc...